Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
aducanumab
3
×
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biogen
bristol-myers squibb
cancer
gilead sciences
novartis
sherlock biosciences
startups
abbvie
acc
accent therapeutics
acquisition
What
bio
roundup
biogen
drug
new
news
activity
adu
approval
approvals
approved
beats
bids
biogen’s
biopharmaceutical
clamped
companies
complicated
convo
covid
delays
depression
developing
dire
earlier
economic
failures
fast
fda
good
group
heart
help
including
ipo
isn’t
littered
lot
medical
medicines
Language
unset
Current search:
aducanumab
×
national
×
biotech
×
photo
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More